Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
Clinical trial NCT04732871 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04732871
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-15
- Primary completion
- 2022-06-06
- Enrollment
- 1720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.